Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GTLB +21.1%, DELL +7.8%, OLLI +3%
Other news:
- QURE +7.1% (submits FDA BLA for accelerated approval of Huntington's gene therapy AMT-130)
- WALD +4.5% (Director/10% owner buys 335,000 shares worth ~$506K)
- HPE +4.3% (in sympathy with Dell beat-and-raise)
- TLX +2.8% (completes Phase 3 BiPASS enrollment, says FDA aligned on U.S. NDA pathway for pre-biopsy PSMA-PET use)
- TEVA +2.2% (Phase 2a celiac study for TEV '408 met primary endpoint)
- PACS +2.1% (to acquire operations of 32 Florida nursing facilities; closes 11 more Eduro sites)
- LAMR +1.6% (increases dividend)
- LFCR +1.6% (signs commercial site-transfer agreement for marketed injectable drug)
- CDNL +1.5% (wins approximately $40 mln Walmart (WMT) sorting facility contract)
- PAGS +1.1% (authorizes $150 mln share repurchase program, sets 2027-2028 dividend target)
- GSM +1% (EU opens interim antidumping review on Chinese silicon metal imports)